Sphinxion Therapeutics, Inc.

San Diego, CA

UEI
MTB1SGR5SSQ7
CAGE
10PM6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1323 Caminito Faro, La Jolla, CA 92037, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
AAV-SPL, a one-time gene therapy for rare and common forms of fibrotic kidney disease - we developed adeno-associated… R42DK148319 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $352,170

Quick answers

Is Sphinxion Therapeutics, Inc. registered in SAM.gov?

Yes. Sphinxion Therapeutics, Inc.'s SAM.gov registration is active through March 2, 2027.

What is Sphinxion Therapeutics, Inc.'s most recent federal award?

Sphinxion Therapeutics, Inc.'s most recent federal grant award is AAV-SPL, a one-time gene therapy for rare and common forms of fibrotic kidney disease - we developed adeno-associated… (R42DK148319), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on September 1, 2026.

On GovTribe

See Sphinxion Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login